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The small intestinal lamina propria (LP) contains a variety of 
immune cells. These include Th17 cells, a subset of activated 
CD4+ T cells characterized by the production of IL-17A, IL-
17F, IL-21, and IL-22 (Korn et al., 2009). Th17 cells have the 
potential to protect or damage the intestinal tissue environ-
ment, so their activity must be tightly regulated (O’Connor et 
al., 2009; Morrison et al., 2011). Several cytokines are known 
to promote the development of Th17 cells; IL-6 and TGF-β 
are required for the differentiation of Th17 cells from naive 
CD4+ T cells, and IL-1β and IL-23 are critical for the main-
tenance of Th17 cells, as well as their differentiation (Zhou 
et al., 2007; Chung et al., 2009). Commensal bacteria con-
tribute to the generation of small intestinal Th17 cells in the 
steady state (Atarashi et al., 2008, 2015; Ivanov et al., 2009). 
In particular, commensal-induced IL-1β production by intes-
tinal macrophages is required for the development of Th17 
cells (Shaw et al., 2012).
IL-1β is a proinflammatory cytokine primarily pro-
duced by activated macrophages and acts as a key mediator in 
various inflammatory diseases, including inflammatory bowel 
disease and rheumatoid arthritis (Sims and Smith, 2010). 
Consequently, mice deficient for IL-1 receptor antagonist 
(IL-1Ra), which competes with IL-1β for receptor binding, 
spontaneously develop arthritis with a marked increase in 
Th17 cells (Nakae et al., 2003; Koenders et al., 2008). In hu-
mans, a decrease in the IL-1Ra to IL-1 ratio has been linked 
to inflammatory bowel disease (Casini-Raggi et al., 1995). 
IL-1Ra secreted by intestinal epithelial cells upon TLR5 ac-
tivation reduces tissue damage (Carvalho et al., 2011), and 
treatment with recombinant IL-1Ra ameliorates intestinal 
graft-versus-host disease by inhibiting Th17 responses (Jan-
kovic et al., 2013). Thus, the balance between IL-1β and IL-
1Ra is critical for controlling Th17 cells and maintaining 
intestinal immune homeostasis.
Eosinophils play proinflammatory roles in helminth infections and allergic diseases. Under steady-state conditions, eosinophils 
are abundantly found in the small intestinal lamina propria, but their physiological function is largely unexplored. In this study, 
we found that small intestinal eosinophils down-regulate Th17 cells. Th17 cells in the small intestine were markedly increased 
in the ΔdblGATA-1 mice lacking eosinophils, and an inverse correlation was observed between the number of eosinophils and 
that of Th17 cells in the small intestine of wild-type mice. In addition, small intestinal eosinophils suppressed the in vitro 
differentiation of Th17 cells, as well as IL-17 production by small intestinal CD4+ T cells. Unlike other small intestinal immune 
cells or circulating eosinophils, we found that small intestinal eosinophils have a unique ability to constitutively secrete high 
levels of IL-1 receptor antagonist (IL-1Ra), a natural inhibitor of IL-1β. Moreover, small intestinal eosinophils isolated from 
IL-1Ra−deficient mice failed to suppress Th17 cells. Collectively, our results demonstrate that small intestinal eosinophils play 
a pivotal role in the maintenance of intestinal homeostasis by regulating Th17 cells via production of IL-1Ra.
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Eosinophils are commonly known as proinflammatory 
cells, mediating the host responses against helminth infections, 
as well as the pathogenesis of various allergic diseases and gas-
trointestinal disorders (Rothenberg and Hogan, 2006). How-
ever, recent studies found that eosinophils also play various 
roles in maintaining homeostasis, such as supporting glucose 
homeostasis by sustaining alternatively activated macrophages 
in adipose tissue (Wu et al., 2011) and promoting the gener-
ation and survival of plasma cells (Chu et al., 2014b; Jung et 
al., 2015). Under steady-state conditions, eosinophils develop 
in the bone marrow and migrate primarily to the gastroin-
testinal tract (Mishra et al., 1999; Rothenberg and Hogan, 
2006). Small intestinal eosinophils have unique phenotypes 
and extended life spans (Carlens et al., 2009; Verjan Garcia et 
al., 2011). However, their function under healthy homeostatic 
conditions remains to be fully elucidated.
In this study, we show that small intestinal eosinophils 
down-regulate Th17 cells by constitutively secreting a large 
amount of IL-1Ra. We found a decrease in serum IL-1Ra 
and a concomitant increase in small intestinal Th17 cells 
in ΔdblGATA-1 mice, which lack eosinophil-lineage cells 
(Yu et al., 2002). In WT mice, the number of Th17 cells in 
the small intestine was inversely correlated with that of eo-
sinophils. Furthermore, eosinophils isolated from the small 
intestine of WT mice, but not of IL-1Ra–deficient mice, in-
hibited the Th17 cells. Our findings demonstrate a hitherto 
unappreciated role of small intestinal eosinophils to regulate 
intestinal homeostasis by controlling Th17 cells.
RES ULTS
Small intestinal Th17 cells are increased in 
eosinophil-deficient mice
Eosinophils accumulate most abundantly in the small in-
testine under steady-state conditions and are absent in 
ΔdblGATA-1 mice (Fig. 1 A). To explore the role of eosin-
ophils in the small intestinal immune system, we analyzed 
T cells in ΔdblGATA-1 mice. As shown in Fig.  1 B, Th1 
and Th17 cells in the small intestine, but not in the spleen 
or mesenteric LNs (MLNs), were significantly increased in 
ΔdblGATA-1 mice on a BALB/c background. On the other 
hand, CD25+Foxp3+ regulatory T (T reg) cells, GATA3+ 
Th2 cells, and RORγt+ innate lymphoid cells (ILC3s) were 
not affected by the absence of eosinophils (Fig.  1, C–F). 
We also observed the same phenomena in the ΔdblGATA-1 
mice on a C57BL/6 background (Fig. 1, G–I).
A recent publication suggested that ΔdblGATA-1 mice 
also showed defects in the generation and function of basophils 
(Nei et al., 2013). This is unlikely to account for the afore-
mentioned findings, as basophils constitute a rare population 
(<0.03%) of leukocytes in the small intestinal LP under steady-
state conditions (Fig. 1 J). Nonetheless, to rule out potential ef-
fects mediated by noneosinophil defects in ΔdblGATA-1 mice, 
we specifically depleted eosinophils in WT C57BL/6 mice by 
injecting them with Siglec-F–specific antibodies every other 
day for 2 wk (Chu et al., 2014b; Griseri et al., 2015). We found 
an increase in small intestinal Th1 and Th17 cells (Fig. 1 K), but 
not T reg or Th2 cells (Fig. 1, L and M), in these mice, mirror-
ing our observations in ΔdblGATA-1 mice. Collectively, these 
results indicate that eosinophils negatively influence Th1 and 
Th17 cell homeostasis in the small intestine.
Small intestinal eosinophils suppress Th17 cells
To further investigate a possible connection between eosin-
ophils and small intestinal Th1/Th17 cells, we analyzed for 
a correlation between the frequency of eosinophils and that 
of Th1/Th17 cells in the small intestine of individual WT 
C57BL/6 and BALB/c mice. Strikingly, we found a strong 
inverse correlation between the frequency of eosinophils and 
that of Th17 cells in both mouse strains (Fig. 2 A). The fre-
quency of Th1 cells was also weakly inverse-correlated with 
eosinophils in C57BL/6 mice, but not in BALB/c mice 
(Fig. 2 B). We also performed correlational analysis between 
the frequency of eosinophils and that of Th2 cells in the small 
intestine using IL-4/GFP reporter (4get) mice and found 
no statistically significant correlation between them under 
steady-state conditions (Fig. 2 C).
To determine whether small intestinal eosinophils sup-
press Th17 cell development, we induced in vitro differenti-
ation of Th17 cells from naive CD4+ T cells in the presence 
or absence of eosinophils purified from the small intestine 
(Fig. S1). Along with TGF-β, IL-6, IL-1β, and IL-23, which 
are conventionally used to induce Th17 cell differentiation, 
we added granulocyte macrophage colony-stimulating fac-
tor (GM-CSF) to promote eosinophil survival during the 
culture. GM-CSF was more effective than IL-5 in maintain-
ing the small intestinal eosinophils alive (Fig.  3, A and B). 
As shown in Fig.  3  C, the addition of small intestinal eo-
sinophils significantly inhibited the Th17 cell differentiation 
in vitro. Furthermore, small intestinal eosinophils suppressed 
IL-17A production by small intestinal CD4+ T cells in vitro 
(Fig. 3 D). These data suggest that small intestinal eosinophils 
suppress the differentiation and/or maintenance of Th17 cells.
Small intestinal eosinophils secrete high levels of IL-1Ra
To explore the factors mediating the suppressive function of 
small intestinal eosinophils, we compared gene expression 
profiles of eosinophils and DCs from the small intestine by 
conducting a genome-wide cDNA microarray analysis. Sur-
prisingly, we found that small intestinal eosinophils, but not 
DCs, strongly express IL-1Ra, which is encoded by Il1rn 
(Fig.  4  A). IL-1Ra antagonizes IL-1α/β by competitively 
binding to their receptor IL-1R and is known to be secreted 
mainly by epithelial cells and mononuclear cells (Garlanda et 
al., 2013). We confirmed the expression of IL-1Ra in small 
intestinal eosinophils using immunoblotting and ELI SA. In 
contrast to eosinophils, IL-1Ra was undetectable in lympho-
cytes and DCs from small intestine and in leukocytes from 
spleen or other gut-associated lymphoid tissues (Fig. 4, B and 
D). IL-1Ra protein was extremely scarce in the small intestinal 
tissue of ΔdblGATA mice and was undetectable in small in-
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Figure 1. Small intestinal Th17 and Th1 cells are increased in eosinophil-deficient mice. (A) Flow cytometry analysis of the frequency of MHC class 
IIneg/low Siglec-Fhigh eosinophils in various tissues from WT BALB/c or eosinophil-deficient (ΔdblGATA-1) mice. (B–D) Flow cytometry analysis of IFN-γ+ and IL-
17A+ (B), CD25+Foxp3+ (C), and GATA3+ (D) CD4+ T cells in the small intestine (SI), spleen (SP), and MLN from ΔdblGATA-1 or littermate control mice (BALB/c). 
FACS plots show cells gated on TCRβ+CD4+ cells. Data in B and C are representative of at least 10 independent experiments (n = 3–5 mice per group per 
experiment), and data in D are representative of four independent experiments (n = 3–5 mice per group per experiment). (E and F) Flow cytometry analysis of 
RORγt+ and GATA3+ (E) and IL-22+ (F) innate lymphoid cells in the small intestine of ΔdblGATA-1 or littermate control mice (BALB/c). FACS plots show cells 
gated on Thy1.2+lineage− (CD3−CD4−CD8α−CD11b−CD11c−CD19−B220−TER119−Gr-1−NK1.1−) cells and are representative of four independent experiments 
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testinal epithelial cells (Fig. 4 C), supporting that it is predom-
inantly produced by eosinophils in the small intestine. During 
in vitro culture, small intestinal eosinophils secreted IL-1Ra 
at extremely high levels, much higher than other well-known 
effector cytokines of eosinophils, including IL-1β, IL-4, IL-5, 
IL-6, IL-13, and TNF (Rothenberg and Hogan, 2006; Jung et 
al., 2015; Fig. 4 E). Unlike small intestinal eosinophils, eosin-
ophils from the bone marrow and blood scarcely produced 
IL-1Ra as determined by RT-PCR and ELI SA (Fig. 4, F and 
G). We found that eosinophils isolated from asthmatic lung 
tissue, unlike the ones from the normal lung, also produce 
IL-1Ra, but at a much lower level compared with small intes-
tinal eosinophils, suggesting that IL-1Ra expression could be 
inducible under certain conditions (Fig. 4 H).
Collectively, these findings show that small intesti-
nal eosinophils secrete a large amount of IL-1Ra under 
steady-state conditions, which could be responsible for the 
suppression of Th17 cells.
GM-CSF promotes small intestinal 
eosinophils to produce IL-1Ra
Next, to determine gut-specific signals inducing expression of 
IL-1Ra in intestinal eosinophils, we first examined involve-
ment of commensal microbiota. Intestinal epithelial cells are 
known to secrete IL-1Ra upon TLR5 activation (Carvalho 
et al., 2011). In contrast, small intestinal eosinophils sponta-
neously secrete IL-1Ra in a MyD88-independent manner 
(Fig. 5 A). Also, there was no significant difference between 
small intestinal eosinophils from specific pathogen–free (SPF) 
and germ-free (GF) mice in the ability to produce IL-1Ra 
(Fig. 5 B), indicating independence from gut microbiota for 
this activity. In this regard, stimulation of bone marrow eo-
sinophils with short-chain fatty acids, which are major end 
products of gut microbial fermentation in the intestine (Kim 
et al., 2013), did not induce IL-1Ra secretion (Fig. 5 C). Fur-
thermore, we found that large intestinal eosinophils produce 
a smaller amount of IL-1Ra compared with small intestinal 
eosinophils (Fig. 5 D). These data indicate that small intes-
tine–specific stimulus other than gut microbiota may play a 
crucial role in IL-1Ra expression by eosinophils.
To further elucidate the factors that promote eosin-
ophils to express IL-1Ra, we stimulated bone marrow eo-
sinophils with a variety of cytokines (GM-CSF, IL-5, IL-33, 
and TGF-β) or retinoic acid, both of which are abundantly 
present in the intestine (Mowat and Agace, 2014; Peterson 
and Artis, 2014). Bone marrow eosinophils, which do not 
normally express IL-1Ra, were found to produce IL-1Ra 
only when cultured with GM-CSF, but not with other cyto-
kines (Fig. 5 E). This response was blocked by the neutraliz-
ing monoclonal antibody against GM-CSF receptor α chain 
(GM-CSFRα; Fig. 5 F). GM-CSF is constitutively secreted 
by the intestinal epithelial cells (Egea et al., 2010) and pro-
motes the activation and survival of eosinophils (Esnault and 
Malter, 2002; Hamilton, 2008). We confirmed that GM-CSF 
is highly expressed in the small intestine compared with bone 
marrow and blood (Fig. 5 G). Furthermore, small intestinal 
eosinophils expressed highly elevated levels of GM-CSF re-
ceptor compared with eosinophils in the bone marrow and 
blood (Fig. 5 H). These findings suggest that small intestinal 
eosinophils produce high levels of IL-1Ra, mostly likely in a 
GM-CSF−dependent manner.
IL-1Ra mediates the suppressive effect of small intestinal 
eosinophils on Th17 cells
IL-1Ra–deficient mice develop spontaneous inflammatory 
arthritis (Nakae et al., 2003; Koenders et al., 2008). However, 
little is known about the alteration of intestinal immune system 
in these mice. We found that the frequency of eosinophils in 
the small intestine was not affected by the absence of IL-1Ra 
(Fig. 6 A). However, Th17 cells were significantly increased in 
the small intestine of IL-1Ra–deficient mice compared with 
littermate control WT mice (Fig. 6 B). In contrast to the small 
intestinal Th17 cells, no significant changes were found in the 
frequency of Th17 cells in the spleen. Th1 and T reg cells 
were not affected both in the small intestine and spleen of 
the IL-1Ra–deficient mice (Fig. 6, B and C). These results 
indicate that IL-1Ra plays an important role in limiting the 
number of Th17 cells in the small intestine.
To test whether small intestinal eosinophils suppress 
Th17 cells by secreting IL-1Ra, we co-cultured small intes-
tinal CD4+ T cells along with eosinophils purified from the 
small intestine of WT or IL-1Ra–deficient mice. As shown in 
Fig. 6 D, small intestinal eosinophils from IL-1Ra−deficient 
mice completely failed to suppress Th17 cells, and addition of 
the recombinant IL-1Ra nicely restored the suppressive ef-
fect of IL-1Ra–deficient eosinophils. These data demonstrate 
that IL-1Ra secreted by small intestinal eosinophils down- 
regulates Th17 cells in the small intestine.
Eosinophils attenuate inflammation by producing IL-1Ra
Serum IL-1Ra was significantly reduced in ΔdblGATA-1 
mice, suggesting that eosinophils, especially the ones in the 
(n = 2–4 mice per group per experiment). (G–I) Frequency of IFN-γ+ and IL-17A+ (G), CD25+Foxp3+ (H), and GATA3+ (I) CD4+ T cells in the small intestine of 
ΔdblGATA-1 or littermate control mice (C57BL/6). ΔdblGATA-1 mice backcrossed with C57BL/6 for at least 10 generations were used. FACS plots show cells 
gated on TCRβ+CD4+ cells and are representative of at least three independent experiments (n = 3–4 mice per group per experiment). (J) Flow cytometry 
analysis of the frequency of c-kit−FcεR1+ and IgE+CD49b+ basophils in peripheral blood and the small intestine. (K–M) Frequency of IFN-γ+ and IL-17A+ (K), 
Foxp3+ (L), and GATA3+ (M) CD4+ T cells in the small intestine of C57BL/6 mice administered every second day with Siglec-F–specific antibodies or isotype 
control (Rat IgG2a) for 2 wk. FACS plots show cells gated on TCRβ+CD4+ cells and are representative of two independent experiments (n = 4 mice per group 
per experiment). Bar graphs show the mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. NS, not significant (unpaired Student’s t test).
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small intestine, are the major sources of systemic IL-1Ra in 
steady-state conditions (Fig. 7 A). To test whether eosino-
phils indeed inhibit inflammatory responses, we induced 
acute inflammation in WT BALB/c or ΔdblGATA-1 mice 
by intraperitoneal injection with LPS and monitored the 
survival of mice. LPS challenge stimulates massive produc-
tion of proinflammatory cytokines, such as IL-1β, IL-6, 
and IL-17A, through damaging the intestinal barrier and 
consequently causes lethality in mice (Wang et al., 1998; 
Li et al., 2011). As shown in Fig. 7 B, ΔdblGATA-1 mice 
were more susceptible to LPS-induced lethality than WT 
mice, and administration of recombinant IL-1Ra–Fc com-
pletely rescued both WT and ΔdblGATA-1 mice from le-
thality. As expected from the mortality rate, the levels of 
proinflammatory cytokines, including IL-1β and IL-17A, 
were much higher in ΔdblGATA-1 mice than in WT 
mice at 6 h after LPS injection (Fig. 7 C). Administration 
of IL-1Ra–Fc suppressed the elevation of proinflamma-
tory cytokines, more so in ΔdblGATA-1 mice. These re-
sults suggest that eosinophils can play an antiinflammatory 
role by producing IL-1Ra.
DIS CUS SION
There are several mechanisms for regulating Th17 cells in the 
small intestine, reflecting the importance of maintaining their 
numbers in the right balance (Bettelli et al., 2006; Esplugues et 
al., 2011). This study for the first time shows that eosinophils 
play a crucial role in controlling Th17 cells in the small intes-
tine. We found that eosinophil-deficient ΔdblGATA-1 mice, 
regardless of genetic background, had much higher frequency 
of Th17 cells in the small intestine. Also, depletion of eosin-
ophils using a Siglec-F–specific monoclonal antibody greatly 
enhanced Th17 cells in the small intestine of WT mice. Our 
results herein suggest that small intestinal eosinophils regulate 
Th17 cell homeostasis by constitutively secreting a copious 
amount of IL-1Ra, a cytokine that inhibits the activity of 
IL-1β and consequently suppresses the differentiation and 
maintenance of Th17 cells.
Although less marked than the effects on Th17 cells, 
we found that the absence of eosinophils in ΔdblGATA-1 
mice was also correlated with an increase in Th1 cells (Fig. 1). 
Supporting this finding, the extract of Ulmus davidiana var. 
japonica Nakai up-regulates eosinophils and reduces the fre-
quencies of Th1 as well as Th17 cells in the small intestine (Lee 
et al., 2013). Contrary to eosinophil-deficient ΔdblGATA-1 
mice, IL-1Ra–deficient mice did not show a significant in-
crease of Th1 cells in the small intestine (Fig. 6 B), therefore, 
small intestinal eosinophils might suppress Th1 cells by secret-
ing other, unidentified cytokines.
IL-1Ra is mainly expressed in mononuclear cells and 
epithelial cells under inflammatory conditions (Sims and 
Smith, 2010), but small intestinal eosinophils produce IL-1Ra 
even under homeostatic conditions. Such IL-1Ra production 
under steady-state conditions seems to be restricted to the 
eosinophils in the small intestine because eosinophils puri-
fied from the bone marrow and blood scarcely secreted IL-
1Ra (Fig. 4 G). After developing and maturing in the bone 
marrow, eosinophils are released into the blood circulation 
and finally migrate to various tissues (Mishra et al., 1999; 
Rothenberg and Hogan, 2006). Through a series of events 
during trafficking, eosinophils are thought to be educated by 
the local tissue-specific microenvironments. The intestine is 
in continuous contact with diverse microbiota and food an-
tigens and is exposed to a vast array of metabolites derived 
from both microbiota and specialized host cells (Hooper et 
al., 2012). Such unique intestinal microenvironment likely 
imprints small intestinal eosinophils to produce a high level 
of IL-1Ra. However, based on our data that small intestinal 
eosinophils from both SPF and GF mice secrete similar lev-
els of IL-1Ra and that metabolites such as retinoic acid and 
short-chain fatty acids fail to induce IL-1Ra production in 
bone marrow eosinophils, commensal microbiota and those 
metabolites do not seem to be crucial for IL-1Ra production 
by small intestinal eosinophils under steady-state conditions 
(Fig. 5 B and C). Instead, our study identified GM-CSF as 
a key factor for inducing IL-1Ra secretion (Fig. 5 E and F). 
GM-CSF is known to stimulate development, survival, and 
Figure 2. Eosinophils are inversely correlated with Th17 cells in the 
small intestine. (A and B) Graphs show the correlation between the per-
centages of eosinophils and IL-17A+ Th17 (A) and IFN-γ+ Th1 cells (B) in 
the small intestine from C57BL/6 or BALB/c mice (n = 27 of C57BL6 [A] and 
31 of C57BL/6 [B], and 21 of BALB/c [A] and 22 of BALB/c [B], respectively). 
(C) Graph shows the correlation between the percentages of IL-4+ Th2 cells 
and eosinophils in the small intestine from 4get mice (n = 15). The cor-
relation coefficient was calculated by Prism software (GraphPad Software). 
Each dot represents one mouse. Mice with various ages (6–20 wk) and sex 
(female and male) were examined.
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effector function of eosinophils (Esnault and Malter, 2002; 
Geering et al., 2013). However, its role of inducing eosino-
phils to secrete an antiinflammatory cytokine has not been 
previously appreciated.
GM-CSF induced high expression of IL-1Ra in the 
bone marrow eosinophils, which normally do not produce 
the cytokine. We also found that basal expression of GM-
CSF in the bone marrow and blood was low, whereas it was 
very high in the small intestine. In the small intestine, Paneth 
cells, among epithelial cells, have been reported to constitu-
tively produce GM-CSF (Egea et al., 2010). In addition, small 
intestinal eosinophils expressed a high level of GM-CSFR 
mRNA, unlike bone marrow and blood eosinophils. The high 
basal level of GM-CSF in the small intestine combined with 
high expression GM-CSFR in the small intestinal eosinophils 
explains the unique ability of the small intestinal eosinophils 
to continuously secrete a large amount IL-1Ra at steady-state 
conditions. Apart from the intestine, GM-CSF levels are highly 
elevated in the lung of OVA-induced allergic asthma model 
(Hamilton, 2008; Su et al., 2008). Accordingly, we found that 
eosinophils purified from asthmatic lung were able to secrete 
IL-1Ra, in contrast to eosinophils from normal lung.
IL-17 enhances the activity of eosinophils either di-
rectly or indirectly, and consequently induces or aggravates 
the eosinophilic inflammatory responses in allergic diseases 
(Cheung et al., 2008; Wakashin et al., 2008; Dias and Banerjee, 
2013). In addition, Th17 cells activated by IL-1 or IL-23 were 
reported to produce GM-CSF (El-Behi et al., 2011; Griseri 
et al., 2012). Therefore, it is plausible that eosinophils activated 
by Th17 cells under inflammatory milieu could acquire the 
ability of IL-1Ra production through GM-CSF/GM-CSFR 
signaling and facilitate a negative feedback control of Th17 
cell homeostasis. Further studies will be required to determine 
whether GM-CSF/GM-CSFR signaling indeed directly in-
duces IL-1Ra expression by the eosinophils in vivo, for ex-
ample by using eosinophil-specific deletion of GM-CSFR.
Under physiological conditions, few eosinophils exist 
in most tissues. Apart from the small intestine, the uterus 
is another organ with high numbers of tissue eosinophils, 
and uterine eosinophils were shown to regulate the estrous 
cycle (Robertson et al., 2000; Gouon-Evans and Pollard, 
2001). Eosinophils in the small intestine and the uterus both 
express CD11c, unlike the eosinophils found in blood and 
lung, and have a markedly longer life span (Carlens et al., 
anti–IL-2 (2.5 µg/ml), GM-CSF (10 ng/ml), TGF-β (5 ng/ml), IL-6 (20 ng/ml), 
IL-1β (20 ng/ml), and IL-23 (10 ng/ml). On day 5, the cells were collected 
and intracellular cytokine staining for IFN-γ and IL-17A in CD4+ T cells 
was analyzed by flow cytometry. (D) Small intestinal CD4+CD25− T cells 
(105) and splenic DCs (104) were cultured with or without small intestinal 
eosinophils (105), as in C, except for the omission of IL-6. On day 5, the cells 
were analyzed for the production of IFN-γ and IL-17A, as in C. FACS plots 
are gated on CD4+ T cells and are representative of at least three similar 
experiments. Bar graphs show the mean ± SEM. *, P < 0.05; **, P < 0.01 
(unpaired Student’s t test).
Figure 3. Small intestinal eosinophils suppress Th17 cells in vitro. 
(A) Small intestinal LP cells were cultured for 1, 2, and 5 d with or without 
GM-CSF (10 ng/ml) or IL-5 (10 ng/ml), and then stained with 7AAD and 
Annexin V for analysis of cell viability. FACS plots show eosinophils (MHC II− 
Siglec-F+ cells) and are representative of two independent experiments. (B) 
Bar graphs show the mean ± SEM of the percentage of Annexin V+ eosin-
ophils. *, P < 0.05; ***, P < 0.001 (two-way ANO VA followed by Bonferroni 
post-test). (C) LN-derived naive CD4+ T cells (105) and splenic DCs (104) 
were cultured with or without small intestinal eosinophils (SI EO; 105) in 
the presence of soluble anti-CD3/CD28 (5 and 2 µg/ml, respectively), neu-
tralizing anti–IFN-γ (5 µg/ml), neutralizing anti–IL-4 (5 µg/ml), neutralizing 
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2009). These findings imply that steady-state tissue-resident 
eosinophils are phenotypically and, most likely, function-
ally different from eosinophils recruited to the tissues under 
nonhomeostatic conditions. Interestingly, although eosin-
ophils are distributed throughout the gastrointestinal tract, 
the frequency of eosinophils in the large intestine at steady 
state is very low, and large intestinal eosinophils show a dis-
tinctive expression pattern of surface proteins, including 
CD11c, ST2, and Ly6C, as compared with small intestinal 
ones (Chu et al., 2014a). Moreover, we found that large in-
testinal eosinophils produce much lower levels of IL-1Ra 
than small intestinal ones (Fig.  5 D). Thus, eosinophils in 
the large intestine seem to be more closely related to the 
proinflammatory eosinophils rather than to other tissue- 
resident eosinophils, such as small intestinal and uterine eo-
sinophils that play homeostatic roles. Consistent with this 
idea, other groups have reported that eosinophils infiltrating 
the colon promote colitis (Ahrens et al., 2008; Waddell et 
al., 2011; Griseri et al., 2015). Numbers and properties of 
eosinophils found in various tissues are likely controlled by 
local milieu. For full characterization of eosinophils in var-
ious tissues and conditions, it would be useful to establish 
the surface markers that can discriminate homeostatic and 
proinflammatory eosinophils.
Figure 4. Small intestinal eosinophils ex-
press high levels of the IL-1Ra. (A) Microar-
ray analysis of DCs and eosinophils (EO) from 
the small intestine of WT C57BL/6 mice. (B) 
Western blot analysis of IL-1Ra protein in cell 
lysates of lymphocytes (Lym), DCs, and eosino-
phils sorted from the small intestinal LP (left). 
(Right) IL-1Ra protein detected from whole-
cell lysates of spleen (SP), MLNs, PPs, and small 
intestinal LP (SI-LP). (C) Western blot analysis 
of IL-1Ra protein in lysates of total small intes-
tinal tissue (jejunum) and small intestinal epi-
thelial cells (SI-IEC) purified from BALB/c (WT) 
or ΔdblGATA-1 (KO) mice. (D) IL-1Ra secreted 
by eosinophils (106) or other cells (Non-EO; 
106) in small intestine during a 24-h culture 
was measured by ELI SA. (E) Various cytokines 
secreted by sorted small intestinal eosinophils 
(106) during a 24-h culture were measured by 
ELI SA. (F) Quantitative RT-PCR analysis of IL-
1Ra in eosinophils isolated from bone marrow, 
blood, or small intestine. (G) IL-1Ra in culture 
supernatants of eosinophils (4 × 104) sorted 
from bone marrow, blood, or small intestine 
was measured by ELI SA. (H) IL-1Ra secreted by 
eosinophils (105) sorted from small intestine, 
normal lung, or allergic asthma-induced lung 
during a 24-h culture was measured by ELI SA. 
Data are representative of two (E and H) or at 
least three (B–D, F, and G) experiments. Bar 
graphs show the mean ± SEM. ND, not de-
tected. *, P < 0.05; **, P < 0.01; ***, P < 0.001 
(unpaired Student’s t test).  on
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In summary, our findings in this study show that eo-
sinophils play a key role in regulating Th17 cells in the small 
intestine and contribute to the maintenance of local intes-
tinal immune homeostasis, highlighting a novel immune 
regulatory function of eosinophils, once considered solely 
as proinflammatory cells.
MAT ERI ALS AND MET HODS
Mice. C57BL/6, BALB/c, ΔdblGATA-1, and IL-4− 
IRES−eGFP (4get) mice were purchased from the Jackson 
Laboratory. MyD88-deficient mice were purchased from 
the Oriental Bio Service, and IL-1Ra–deficient mice were 
provided by Y. Iwakura (University of Tokyo, Tokyo, Japan). 
For generation of C57BL/6 background ΔdblGATA-1 mice, 
BALB/c background ΔdblGATA-1 mice were backcrossed 
>10 generations with C57BL/6 mice. The mice were main-
tained in SPF facilities at the Pohang University of Science 
and Technology (POS TECH) and Research Institute for 
Microbial Diseases of Osaka University. A colony of GF 
C57BL/6 mice was established at POS TECH from breed-
ers obtained from A. Macpherson (Bern University, Bern, 
Switzerland). GF mice were maintained in sterile flexible 
film isolators (Class Biological Clean Ltd.), and GF status was 
monitored monthly by anaerobic and aerobic culture of cecal 
contents. All procedures were approved by the Animal Care 
and Use Committee of POS TECH and the Animal Research 
Committee of Osaka University.
Cell preparation. To isolate LP cells from the intestine, fat tis-
sues and Peyer’s patches (PPs) were removed, and the intestine 
Figure 5. Eosinophils secrete IL-1Ra upon 
GM-CSF stimulation. (A and B) IL-1Ra in the 
culture supernatant of small intestinal eosino-
phils sorted from MyD88-deficient (KO; 105) or 
littermate control (WT; 105) mice (A) and SPF 
(5 × 104) or GF (5 × 104) mice (B) after a 24-h 
culture was measured by ELI SA. (C) IL-1Ra in 
the culture supernatant of bone marrow eo-
sinophils (2 × 104) after a 3 or 5 d culture with 
acetate (1 mM), butyrate (1 mM), or propionate 
(1 mM) was measured by ELI SA. (D) IL-1Ra in 
culture supernatant of eosinophils (5 × 104) 
sorted from small intestine or large intestine 
was measured by ELI SA. (E) IL-1Ra in the cul-
ture supernatant of bone marrow eosinophils 
(2 × 104) after a 3 or 5 d culture with GM-CSF 
(10 ng/ml), IL-5 (10 ng/ml), IL-33 (10 ng/ml), 
TGF-β (5 ng/ml), or retinoic acid (RA; 10 mM) 
was measured by ELI SA. (F) IL-1Ra in the cul-
ture supernatant of bone marrow eosinophils 
(1.5 × 104) after a 5 d culture with GM-CSF 
(10 ng/ml) in the presence of GM-CSF recep-
tor α blocking antibodies (α-GM-CSFRα; 8 µg/
ml) or isotype control (Rat IgG2a; 8 µg/ml) was 
measured by ELI SA. (G) Quantitative RT-PCR 
analysis of GM-CSF in bone marrow, blood, or 
jejunum (SI). (H) Quantitative RT-PCR analy-
sis of GM-CSF receptor in eosinophils sorted 
from bone marrow, blood, or small intestine. 
All data are representative of at least three in-
dependent experiments. Bar graphs show the 
mean ± SEM. *, P < 0.05, ***, P < 0.001; NS, not 
significant (unpaired Student’s t test).  on
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was opened longitudinally, washed in PBS, and cut into 1-cm 
sections. The epithelial cell layer was removed by vigorous 
stirring in FACS buffer (PBS containing 3% FBS, 20  mM 
Hepes, 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM 
sodium pyruvate, and 10 mM EDTA) for 20 min at 37°C. 
The intestinal fragments were shaken in PBS, minced, and 
Figure 6. Small intestinal eosinophils suppress Th17 cells by producing IL-1Ra. (A) Flow cytometry analysis of the frequency of eosinophils in 
IL-1Ra–deficient (KO) or littermate control BALB/c mice (WT). FACS plots are representative of three independent experiments (n = 3 mice per group 
per experiment). Bar graphs show the mean ± SEM of pooled data. (B and C) Frequency of IFN-γ+ and IL-17A+ (B) and Foxp3+ (C) CD4+ T cells in the 
small intestine (SI) or spleen (SP) from IL-1Ra–deficient or littermate control BALB/c mice. FACS plots show cells gated on TCRβ+CD4+ cells and are 
representative of three independent experiments (n = 3−5 mice per group per experiment). Bar graphs show the mean ± SEM of pooled data. (D) Small 
intestinal CD4+CD25− T cells (105) and splenic DCs (104) were cultured with small intestinal eosinophils (105) from WT BALB/c or IL-1Ra–deficient mice 
in the presence of anti-CD3/CD28, neutralizing anti–IFN-γ, neutralizing anti–IL-4, neutralizing anti–IL-2, GM-CSF, TGF-β, IL-1β, and IL-23. IL-1Ra was 
added to certain cultures. After 5 d of culture, cells were collected and intracellular cytokine staining for IFN-γ and IL-17A in CD4+ T cells was analyzed 
by flow cytometry. FACS plots show cells gated on CD4+ T cells and are representative of four similar experiments. Bar graphs show the mean ± SEM. 
*, P < 0.05; **, P < 0.01. NS, not significant (unpaired Student’s t test).
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digested in RPMI-1640 containing 3% FBS, 20 mM Hepes, 
100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM sodium 
pyruvate, 1 mM nonessential amino acids, 400 U/ml collage-
nase D (Roche), and 100 µg/ml DNase I (Roche) at 37°C for 
45 min with continuous stirring. EDTA was added to a final 
concentration of 10 mM, and the cell suspension was incu-
bated for an additional 5 min at 37°C. The cell suspension was 
then filtered through a 100-µm cell strainer and pelleted by 
centrifugation for 5 min at 1,300 rpm. The pellet was sub-
jected to 40/75% Percoll (GE Healthcare) density-gradient 
centrifugation for 20 min at 2,000 rpm at room temperature. 
Cells at the interface were collected, washed, and used for 
analysis and culture. To isolate epithelial cells from the intes-
tine, intestinal fragments were shaken in FACS buffer con-
taining 1 mM EDTA for 30 min at 37°C, the cell suspension 
was filtered through a 100-µm cell strainer, and epithelial cells 
were enriched by 25/40% Percoll density-gradient centrifu-
gation. Blood samples were lysed with ACK (Ammoni-
um-Chloride-Potassium) lysis buffer on ice and used for 
FACS analysis. Thymi were minced using curved scissors and 
digested the same way as the intestinal fragments, and the cells 
were then spun through a 17.5% Accudenz (Accurate Chem-
ical & Scientific Co.) solution. Cells at the interface were col-
lected, washed, and used for FACS analysis. To isolate DCs 
from spleen, the organs were minced and digested in RPMI-
1640 containing collagenase D and DNase I as described in 
intestinal LP cell isolation section. The cells were spun 
through a 17.5% Accudenz (Accurate Chemical & Scientific 
Co.) solution and separated by density-gradient centrifuga-
tion for 20 min at 2,000 rpm at room temperature. Cells at 
the interface were collected, washed, and used for analysis and 
culture. To isolate lymphocytes, spleens were mechanically 
minced through a 100-µm cell strainer in the presence of 
FACS buffer, and RBCs were lysed using ACK lysis buffer. 
The cells were washed and used for analysis and culture.
Flow cytometry. Fc receptors were blocked with anti–mouse 
CD16/CD32 (2.4G2; BD), and the cells were stained using 
the following antibodies: anti-CD11b (M1/70; BD), anti- 
CD11c (HL3; BD), anti-MHC class II (M5/114.15.2; eBio-
science), anti-CCR3 (83103; BD), anti–Siglec-F (E50-2440; 
BD), anti–c-kit (2B8; BD), anti-FcεR1 (MAR-1; eBiosci-
ence), anti-CD49b (DX5; BioLegend), anti-IgE (RME-1; 
BioLegend), 7AAD (BD), Annexin V (BD), anti-CD3e (145-
2C11; BD), anti-CD8α (53-6.7; BD), anti-CD19 (1D3; BD), 
anti-B220 (RA3-6B2; BD), anti-TER119/Ly-76 (TER-
119; BD), anti–Gr-1 (RB6-8C5; BD), anti-NK1.1 (PK136; 
eBioscience), anti-Thy1.2 (53-2.1; eBioscience), anti-TCRβ 
Figure 7. An antiinflammatory function of eosinophils. (A) IL-1Ra in serum from ΔdblGATA-1 or littermate control mice (WT) was measured by ELI 
SA. Results shown are representative of at least three independent experiments (n ≥ 4 mice per group per experiment). Bar graphs show the mean ± 
SEM. *, P < 0.05 (unpaired Student’s t test). (B) Mice were intraperitoneally injected with 15 mg/kg of LPS. IL-1Ra–hybrid Fc fusion protein (IL-1Ra–Fc; 
25 mg/kg) was injected 4 h before and 20 min after the injection of LPS. Thereafter, mice were treated four times (every 3 h) with IL-1Ra–Fc. Survival of 
mice was monitored for 7 d (WT, n = 10; WT + IL-1Ra–Fc, n = 9; ΔdblGATA-1, n = 10; ΔdblGATA-1 + IL-1Ra–Fc, n = 10). Data are representative of three 
similar experiments. Statistical curve comparison was analyzed by Log-rank (Mantel-Cox) test. *, P < 0.05; ***, P < 0.001. (C) Serum samples of mice in 
B were collected at 6 h after LPS injection and cytokines were measured. Data are representative of two independent experiments. Bar graphs show the 
mean ± SEM. ND, not detected. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (unpaired Student’s t test).  o
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(H57-597; BioLegend), anti-CD25 (PC61.5; eBioscience), 
anti-CD4 (RM4-5, eBioscience), anti–IFN-γ (XMG1.2; 
eBioscience), anti–IL-13 (eBio13A; eBioscience), anti–IL-
17A (TC11-18H10; BD), anti-RORγt (B2D; eBioscience), 
anti-GATA3 (TWAJ; eBioscience), anti-Foxp3 (FJK-16s; 
eBioscience), and streptavidin (BD). For intracellular tran-
scription factor staining, Foxp3/transcription factor staining 
buffer set (eBioscience) was used. For intracellular cytokine 
staining, cells were stimulated with phorbol 12-myristate 
13-acetate (PMA; 50 ng/ml; Sigma-Aldrich) and ionomy-
cin (750 ng/ml; Sigma-Aldrich), or recombinant mouse (rm) 
IL-1β (40 ng/ml; R&D Systems) and rm IL-23 (20 ng/ml; 
R&D Systems) in the presence of monensin (GolgiStop; BD) 
for 4 h, and stained using a Cytofix/Cytoperm staining kit 
(BD). Data were acquired on an LSRFortessa (BD) and ana-
lyzed with FlowJo software (Tree Star).
Cell sorting. LN cells were stained with anti-CD4, anti- 
CD25, anti-CD44 (IM7; BD), and anti-MHC class II to 
isolate MHC II−CD4+CD25−CD44− naive CD4+ T cells. 
Splenocytes were stained with anti-CD11c and anti-MHC 
class II to isolate MHC II+CD11c+ DCs. Blood cells were 
stained with anti-MHC class II, anti-CCR3, and anti–Siglec- 
F, and bone marrow cells were stained with anti–MHC 
class II, anti-CD11b, and anti–Siglec-F to isolate MHC II− 
CCR3highSiglec-Fhigh and MHC II−CD11bintSiglec-Fhigh eo-
sinophils, respectively. Small intestinal epithelial cell prepara-
tion was stained with anti-CD45 (30-F11; eBioscience) and 
anti-EpCAM (G8.8; BioLegend) to isolate CD45−EpCAM+ 
intestinal epithelial cells. Small intestinal LP cells were 
stained with anti-CD4, anti-CD25, anti–MHC class II, and 
anti–Siglec-F; MHC II−Siglec-F+ eosinophils and MHC II− 
Siglec-F−CD4+CD25− T cells were sorted on a MoFlo As-
trios or MoFlo XDP (Beckman Coulter).
Real-time PCR. Total RNA was extracted using TRIzol re-
agent (Invitrogen), and cDNA was synthesized with Quanti-
Tect Reverse Transcription kit (QIA GEN) according to the 
manufacturer’s protocol. Real-time PCR was performed 
using SYBR Premix Ex Taq (Takara Bio Inc.) and ViiA 7 
system (Applied Biosystems). The following primer pairs 
were used: GM-CSF (Csf2), 5′-GCA TGT AGA GGC CAT 
CAA AGA-3′ and 5′-CGG GTC TGC ACA CAT GTTA-
3′; GM-CSFRα, 5′-GCG GGC GAC ACG AGG ATG AAG 
CAC-3′ and 5′-CTA GGG CTG CAG GAG GTC CTT CCT-
3′; IL-1Ra, 5′-TAC TGT GGA CAC CAC CCT CA-3′ and 
5′-TCT GCC TCC AAG CAA AAG AT-3′; HPRT, 5′-TCA 
ACA ATC AAG ACA TTC TTT CCA-3′ and 5′-CAG ACT 
GAA GAG CTA CTG TAA TGA TCA-3′.
Microarray analysis. Total RNA was extracted from small in-
testinal LP DCs and eosinophils using TRIzol reagent (Invitro-
gen) and RNeasy kit (QIA GEN), and cDNA was synthesized 
with a SuperScript First-Strand Synthesis System for RT-PCR 
(Invitrogen) according to the manufacturer’s protocol. The 
cDNA was hybridized to Murine Genome 430 2.0 microar-
ray chips (Affymetrix) according to the manufacturer’s instruc-
tions. Hybridized chips were stained, washed, and scanned with 
a GeneArray Scanner (Affymetrix). Microarray Suite (Version 
5.0; Affymetrix) and GeneSpring (Silicon Genetics) software 
were used for data analysis. All datasets have been deposited 
at the National Center for Biotechnology Information Gene 
Expression Omnibus under accession no. GSE77545.
Immunoblotting. Whole-cell lysates were prepared from the 
spleen, MLN, PPs, and small intestinal LP. Lysates were also 
prepared from small intestinal tissues (jejunum), FACS-sorted 
small intestinal epithelial cells, LP lymphocytes, LP DCs, and 
LP eosinophils isolated as described above. Blots were probed 
with anti–IL-1Ra (BAF-480; R&D Systems) using anti–β- 
Actin (sc-47778; Santa Cruz Biotechnology, Inc.) as a control. 
Streptavidin-conjugated horseradish peroxidase (DY998; R&D 
Systems) was used as a secondary antibody, and band images 
were visualized with ImageQuant LAS4000 (GE Healthcare).
Cytokine measurements in cell culture supernatants and 
serum. FACS-sorted eosinophils were cultured in RPMI-1640 
containing 10% FBS, 10 mM Hepes, 100 U/ml penicillin, 100 
µg/ml streptomycin, 50 µg/ml gentamicin, 1 mM sodium py-
ruvate, 55 µM 2-mercaptoethanol, 1 mM nonessential amino 
acids, and 2  mM l-Glutamine at 37°C. Mouse ELI SA kits 
(IL-1Ra/IL-1F3; R&D Systems; IL-1β, IL-4, IL-5, IL-6, IL-
13, IL-12p40, and IL-17A; eBioscience; TNF; BD) were used 
according to the manufacturer’s instructions to measure these 
cytokine levels in mouse serum or cell culture supernatants.
In vitro co-culture. CD4+ T cells (105) were sorted from LNs 
or small intestinal LP and cultured with splenic DCs (104) in 
the presence or absence of small intestinal eosinophils (105) 
from WT or IL-1Ra–deficient mice. The following antibodies 
and cytokines were included in the culture: anti-CD3e (5 µg/
ml; 145-2C11; BD), anti-CD28 (2 µg/ml; 37.51; BD), neutral-
izing anti–IFN-γ (5 µg/ml; XMG1.2; eBioscience), neutraliz-
ing anti–IL-4 (5 µg/ml; 11B11; eBioscience), neutralizing 
anti–IL-2 (2.5 µg/ml; S4B6; BD), recombinant human TGF-β 
(5 ng/ml; R&D Systems), rm IL-1β (20 ng/ml; R&D Systems), 
rm IL-6 (20 ng/ml; R&D Systems), rm IL-23 (10 ng/ml; R&D 
Systems), rm GM-CSF (10 ng/ml; R&D Systems), and rm IL-
1Ra (200 ng/ml; R&D Systems). On day 5, the cells were stim-
ulated with PMA (50 ng/ml) and ionomycin (750 ng/ml) in 
the presence of monensin for 4  h, and the cells producing 
IFN-γ and IL-17A were analyzed by flow cytometry.
Depletion of eosinophils. C57BL/6 mice were injected six 
times with 25 µg of Siglec-F–specific antibodies (R&D Sys-
tems) or isotype control (Rat IgG2a; R&D Systems) for 2 wk 
(every second day) and analyzed 3 d later.
Murine model of allergic asthma. BALB/c mice were sensitized 
by an intraperitoneal injection of 100 µg OVA (Sigma-Aldrich) 
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plus 2 mg aluminum hydroxide (Sigma-Aldrich) on days 0 and 
14, after which the mice were challenged by intranasal adminis-
tration of 75 µg OVA on days 21, 22, 28, and 29. Pulmonary 
inflammation was evaluated and cells were isolated from lung 
tissues at 48 h after the final allergen challenge (on day 31).
LPS challenge. BALB/c or ΔdblGATA-1 mice were intraper-
itoneally injected with 15 mg/kg of LPS (Escherichia coli 
055:B5; Sigma-Aldrich). 25 mg/kg of IL-1Ra–hybrid Fc fu-
sion protein (IL-1Ra–Fc; Handok Pharmaceuticals Co.) was 
injected 4 h before and 20 min after the injection of LPS. 
Thereafter, mice were treated four times (every 3 h) with IL-
1Ra–Fc. Survival of mice was monitored for 7 d.
Statistical analysis. Statistical analysis was performed with 
Prism 5 software (GraphPad Software). For statistical compar-
isons between groups, unpaired Student’s t test, two-way 
ANO VA or log-rank (Mantel-Cox) test was performed when 
indicated. P-values <0.05 were considered statistically signif-
icant (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Online supplemental information. Fig. S1 shows the gating 
strategy for small intestinal eosinophils. Online supplemental 
material is available at http ://www .jem .org /cgi /content 
/full /jem .20141388 /DC1.
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